Methods and pharmaceutical compositions for the treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10894042
APP PUB NO 20180296549A1
SERIAL NO

15525771

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods and pharmaceutical compositions for the treatment of cancer. More particularly, the present invention relates to a method of treating cancer in subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one OX1R antagonist.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • INSERM ( INSTITUT NATIONAL DE LA SANTA ET DE LA RECHERCHE MEDICALE); UNIVERSITE PARIS DIDEROT—PARIS 7

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Couvineau, Alain Paris, FR 13 4
Gratio, Valérie Paris, FR 2 0
Nicole, Pascal Paris, FR 4 0
Voisin, Thierry Paris, FR 12 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 19, 2024
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 19, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 19, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00